Why Compass Pathways (CMPS) is a 5-bagger: $210/share Thomas George·October 9, 2020Grizzle outlines the structural share price upside of Compass Pathways and its psilocybin drug: COMP 360 to treat...Psychedelics·4 Comments·
The Most Anticipated Psychedelic IPO: Compass Pathways (CMPS) Thomas George·September 18, 2020Grizzle sits down with Terry Chong (Partner, Grizzle Venture) to discuss one of the most anticipated psychedelic IPOs:...Psychedelics·3 Comments·
